TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Brain effects measured with fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain effects measured with TMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Desaturation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Intervention Feasibility
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Respiratory system reactance (Xrs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 24-hour mean glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Beck Depression Inventory (BDI) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility measured by count of remaining Sticks
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Abbreviated Acceptability Rating Profile
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cmax of HRS-1780 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of HRS-1780 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t1/2 of HRS-1780 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of HRS-1780 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-inf of HRS-1780 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Directed Learning Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Bone microarchitecture changes at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone microarchitecture changes at 18 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ascending aortic dilatation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Readiness for Discharge From PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac events grade II or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUROC of the self-evaluation tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful intubation at the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Global myocardial flow reserve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Global stress myocardial blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acute Symptomatic Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Osteoarthritis Outcome Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Composite endpoint of worsening heart failure requiring unplanned hospitalizations or urgent visits, and cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: annual economic impact related to treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Yo-Yo test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with acute rejection diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in self-reported spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change amount of ALT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Fugl Meyer lower extremity test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fugl Meyer upper extremity test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Positive conversion rate of 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody Geometric Mean Titer (GMT) of 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serious Adverse Events (SAE) incidence within 6 months
Endpoint domain: Adverse events/effects
Primary endpoint: Acute Nausea Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed Nausea Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite recovery score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Frailty scale results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Team Emergency Assessment Measure score (TEAM score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PI - Plaque Index (Silness and Löe, 1964)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Edinburgh Postpartum Depression Scale (EPDS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sustained Pain Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in trait anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in emotion processing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Survival for one year
Endpoint domain: Mortality/survival
Primary endpoint: Occurrence of adverse events during treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Splanchnic oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Investigator Clinical Efficacy Grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration of JNJ-40411813
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reading Speed for Individual Words
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reading Speed for Sentences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reading Speed for Natural Text Samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported pain level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional capacity: 10 Meter Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related quality of life Questionnaire: Short Form 36 (SF36) v2
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: time-weighted average of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall Patient Reported Change of Bladder Overactivity Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 3-year disease free survival rate (DFSR)
Endpoint domain: Mortality/survival
Primary endpoint: Pain during nasogastric tube insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in maximal exercise capacity (VO2 peak) at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in sub-maximal exercise capacity (6MWD) at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Knee Extension Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Maastricht Vital Exhaustion Score (MQ)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Falls Efficacy Scale-International (FES-I)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Migraine-induced Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vocal cord EMG - Burst amplitude (mV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Vocal cord EMG - Burst duration (ms)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Vocal cord EMG - Burst frequency (Hz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: expression of ACC1 in placenta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Aesthetic Improvement of the Face
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptomatic treatment of disorders of cognitive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with symptomatic laboratory confirmed COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: Post-treatment GMTs in SARS-CoV2 S and/or RBD antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of participants with post-treatment seroresponse (> 4-fold rise in titers) to the S and/or RBD antigens of GRAd-COV2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Direct diagnosis of disseminated Lyme disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the Behavioural Inattention Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: vancomycin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No sinus arrest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: No AVB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence rate of COVID19 infection
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of dose limited toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: The change of hepatic enzyme concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function outcomes
Primary endpoint: Changes from baseline in liver function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function outcomes
Primary endpoint: Opioid consumption in Post-anesthesia Care Unit (PACU)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Post-Anesthesia Care Unit Stay duration
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Acceptability proportion of HIV self-test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Protocol Compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Protocol Completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Audio Intelligibility
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: incidence of first atrial fibrillation (AF)
Endpoint domain: Mortality/survival
Primary endpoint: Monofilament test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Objective Response (Partial Response or Complete Response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vision-related function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serious adverse event (SAE) within 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Identification of metastatic lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Completion of Single session intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Wordless Picture Book
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Cambridge Neuropsychological Test Automated Battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Spirituality Scale for Chinese Elders (SSCE)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Training safety
Endpoint domain: Adverse events/effects
Primary endpoint: Change of other-reported anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of self-reported anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of psychological distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fracture resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Average gingival thickness change (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of acceptance of prenatal carrier screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of patient coronary events/myocardial perfusion decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Axial Visualization Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Screw Placement Feasibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hemoglobin Functional Oxygen Saturation (SPO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotion Dysregulation Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weiner's Acceptability, Appropriateness, & Feasibility of Intervention Scales
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Provider Self-Efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Participants With Clinically Significant Changes in Vital Signs During the Study
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Clinically Significant Changes in Electrocardiogram (ECG) During the Study
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart failure re-hospitalization rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: FACIT-Sp-12
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Proportion of patients achieving or remaining at LDH<1.5 ULN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validity of the camera-based signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of the camera-based signals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Distance deviation at 2 months after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of CAG repeats on exon 1 of AR gene
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device Usability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Duration of N3 Sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of N3 Sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regional deformation between participant left atrial geometry and SSM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Location of AF drivers defined by AcQTrack
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of AF drivers defined by AcQTrack
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area Under the Curve (AUC) of the Global Score of the Acute Rhinitis Symptoms Severity Questionnaire (ARSSQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in scapular muscles strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in kyphosis index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain intensity level
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Chemogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early patient reported gastro-oesophageal toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ambulatory function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Respiratory Distress Observation Scale (C-RDOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: maximal pain associated with wound injury closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PDH dephosphorylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: expression of OXPHOS proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: expression of MCU protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bleeding phenotype in hemophilia A and B carriers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Abnormal CPET
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of Adverse Events (AE) after CAR-T infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma Tumor Necrosis Factor alpha (TNF-α)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma Interleukin-6 (IL-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean change of C-reactive Protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change of Erythrocyte Sedimentation Rate (ESR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Disease Activity Score (DAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multidimensional Quality of Life Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Participant recruitment efficiency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement rate
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Huntingtin homocysteinylated level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total lung sonography scores (LUS) at T2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative improvement of symptoms of defecatory obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percent of wounds healed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean Number of CVC Fractures
Endpoint domain: Adverse events/effects
Primary endpoint: Forced Expiratory Volume in one Second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Bauer questionnaire at post-operative day 1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Brice questionnaire at post-operative day 1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: First request for analgesia
Endpoint domain: Adverse events/effects
Primary endpoint: Migraine Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Cochin Hand Function Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Feasibility of 5-day HFRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of HPV high risk infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Self-Efficacy for Mammography
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gastroesophageal reflux measured by pH metry test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of acute cerebrovascular disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Interleukin-1-beta (IL-1β)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Tumor necrosis factor alpha (TNF-α)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Infusion volume of distension medium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Richness of the gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sirius red staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunopathological staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported diarrhea rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pediatric Balance Beam Test (PBBT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early Visual Gait Score (EVGS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KINDL (Quality of Life Questionnaire for Children)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Fine Motor Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes